Cancers, Vol. 16, Pages 1053: Chimeric Antigen Receptor-Modified T Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer: Promise and Potential

Cancers, Vol. 16, Pages 1053: Chimeric Antigen Receptor-Modified T Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer: Promise and Potential Cancers doi: 10.3390/cancers16051053 Authors: Leah R. Tharian Shiv Verma Sanjay Gupta Prostate cancer, the most common cancer among males, has a mortality rate of approximately 29,000 deaths each year in the United States alone [...]
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Editorial Source Type: research